proline has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albrecht, C; Berry, AK; Betageri, R; Ceci, A; Ermann, M; Gemkow, MJ; Hickey, ER; Jenkins, JE; Khor, S; Nagaraja, NV; Riether, D; Romig, H; Sauer, A; Thomson, DS; Wu, L; Zindell, R | 1 |
| Jakobsen, J; Sidenius, P | 1 |
1 review(s) available for proline and Diabetic Neuropathies
| Article | Year |
|---|---|
Axonal transport in experimental diabetes.
Topics: Acetylcholinesterase; Actins; Animals; Axonal Transport; Blood Glucose; Choline O-Acetyltransferase; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glycoproteins; Intermediate Filaments; Kinetics; Male; Proline; Rats; Rats, Inbred Strains; Tubulin | 1985 |
1 other study(ies) available for proline and Diabetic Neuropathies
| Article | Year |
|---|---|
Selective CB2 receptor agonists. Part 2: Structure-activity relationship studies and optimization of proline-based compounds.
Topics: Animals; Diabetic Neuropathies; Half-Life; Humans; Isoxazoles; Ligands; Male; Microsomes, Liver; Proline; Protein Binding; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Solubility; Structure-Activity Relationship | 2015 |